IL18 and cancer: First, IL-18 may exert its tumor-suppressive influences by stimulating IFN-γ production, promoting Th1 differentiation, enhancing the cytotoxic capacities of CD8+ lymphocytes and natural killer cells [7], inducing cancer cells to undergo programmed cell death [10], and suppressing the angiogenesis [7,11].